Skip to main content
. 2021 Feb 20;11(2):540. doi: 10.3390/nano11020540

Figure 1.

Figure 1

Recoveries of different elution volumes using different solvents for residual analytes. (A) Anticonvulsants and β-blockers (atenolol (ANL), propranolol hydrochloride (PPNL) and carbamazepine (CBZ)), (B) parabens (methylparaben (MP), ethylparaben (EP), propylparaben (PP) and butylparaben (BP)), (C,D) fluoroquinolones (danofloxacin (DANO), enrofloxacin (ENRO), levofloxacin (LEVO)).